by SoP | May 28, 2017 | News |
Small, randomized clinical trial reported measurable, but transient, benefits after single dose of suramin, highlighting novel causative theory and need for more, larger and longer trials By Scott LaFee In a small, randomized Phase I/II clinical trial (SAT1),...
